{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:00:38Z","timestamp":1761919238209},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.cancergencyto.2009.03.005","type":"journal-article","created":{"date-parts":[[2009,7,13]],"date-time":"2009-07-13T04:09:29Z","timestamp":1247458169000},"page":"9-18","source":"Crossref","is-referenced-by-count":27,"title":["Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia"],"prefix":"10.1016","volume":"193","author":[{"given":"Joshua D.","family":"Schiffman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuker","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Welch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman J.","family":"Lacayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary V.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malek","family":"Faham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanlee P.","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1999","series-title":"Cancer incidence and survival among children and adolescents: United States SEER Program 1975\u20131995","key":"10.1016\/j.cancergencyto.2009.03.005_bib1"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib3","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood-2006-01-024729","article-title":"Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)","volume":"109","author":"Schultz","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib4","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2007-04-084293","article-title":"Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group","volume":"111","author":"Lange","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2141.2005.05773.x","article-title":"Childhood acute lymphoblastic leukaemia and relapse","volume":"131","author":"Gaynon","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1634\/theoncologist.12-3-341","article-title":"Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia","volume":"12","author":"Meshinchi","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/pbc.20722","article-title":"Childhood acute lymphoblastic leukemia in the age of genomics","volume":"46","author":"Carroll","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-4608(00)00310-1","article-title":"Importance of using comparative genomic hybridization to improve detection of chromosomal changes in childhood acute lymphoblastic leukemia","volume":"123","author":"Jarosov\u00e1","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib9","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1038\/sj.onc.1210190","article-title":"Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization","volume":"26","author":"Strefford","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib10","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib11","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.leu.2404691","article-title":"High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression","volume":"21","author":"Kuiper","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood-2007-05-088310","article-title":"Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray","volume":"111","author":"Kawamata","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib13","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1182\/blood.V85.9.2321.bloodjournal8592321","article-title":"Frequent deletion of p16INK4a\/MTS1 and p15INK4b\/MTS2 in pediatric acute lymphoblastic leukemia","volume":"85","author":"Okuda","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood.V97.2.572","article-title":"Hemizygous p16INK4A deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse","volume":"97","author":"Carter","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib15","first-page":"1537","article-title":"Association of chromosome arm 9 p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group","volume":"94","author":"Heerema","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib16","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.leu.2403769","article-title":"CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia","volume":"19","author":"van Zutven","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib17","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1093\/nar\/gni177","article-title":"Allele quantification using molecular inversion probes (MIP)","volume":"33","author":"Wang","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib18","doi-asserted-by":"crossref","first-page":"R246","DOI":"10.1186\/gb-2007-8-11-r246","article-title":"Analysis of molecular inversion probe performance for allele copy number determination","volume":"8","author":"Wang","year":"2007","journal-title":"Genome Biol"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nbt821","article-title":"Multiplexed genotyping with sequence-tagged molecular inversion probes","volume":"21","author":"Hardenbol","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/gcc.20549","article-title":"Amplification of 11q13 in ovarian carcinoma","volume":"47","author":"Brown","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2407-8-17","article-title":"Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities","volume":"8","author":"Press","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib22","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.1158\/0008-5472.CAN-06-0595","article-title":"Molecular inversion probe analysis of gene copy alterations reveals distinct categories of colorectal carcinoma","volume":"66","author":"Ji","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/biostatistics\/kxh008","article-title":"Circular binary segmentation for the analysis of array-based DNA copy number data","volume":"5","author":"Olshen","year":"2004","journal-title":"Biostatistics"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib24","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1093\/bioinformatics\/bti407","article-title":"A practical false discovery rate approach to identifying patterns of differential expression in microarray data","volume":"21","author":"Grant","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib25","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1200\/JCO.1996.14.5.1512","article-title":"Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia","volume":"14","author":"Heyman","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib26","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1182\/blood-2008-06-165027","article-title":"Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia","volume":"112","author":"Yang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib27","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.1164266","article-title":"Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia","volume":"322","author":"Mullighan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/gcc.20616","article-title":"Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks","volume":"48","author":"Bungaro","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2009.03.005_bib29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2008-07-166801","article-title":"A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups","volume":"113","author":"Sulong","year":"2009","journal-title":"Blood"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809001496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809001496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T10:12:59Z","timestamp":1589969579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460809001496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0165460809001496"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2009.03.005","relation":{},"ISSN":["0165-4608"],"issn-type":[{"type":"print","value":"0165-4608"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}